Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Extramural depth of tumor invasion at thin-section MR in rectal cancer: Associating with prognostic factors and ADC value.

Tong T, Yao Z, Xu L, Cai S, Bi R, Xin C, Gu Y, Peng W.

J Magn Reson Imaging. 2013 Oct 31. doi: 10.1002/jmri.24398. [Epub ahead of print]

PMID:
24307597
[PubMed - as supplied by publisher]
2.

Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness.

Curvo-Semedo L, Lambregts DM, Maas M, Beets GL, Caseiro-Alves F, Beets-Tan RG.

J Magn Reson Imaging. 2012 Jun;35(6):1365-71. doi: 10.1002/jmri.23589. Epub 2012 Jan 23.

PMID:
22271382
[PubMed - indexed for MEDLINE]
3.

Assessment of aggressiveness of rectal cancer using 3-T MRI: correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors.

Akashi M, Nakahusa Y, Yakabe T, Egashira Y, Koga Y, Sumi K, Noshiro H, Irie H, Tokunaga O, Miyazaki K.

Acta Radiol. 2013 Sep 4;55(5):524-531. [Epub ahead of print]

PMID:
24005562
[PubMed - as supplied by publisher]
4.

Correlation of apparent diffusion coefficient value with prognostic parameters of endometrioid carcinoma.

Inoue C, Fujii S, Kaneda S, Fukunaga T, Kaminou T, Kigawa J, Harada T, Ogawa T.

J Magn Reson Imaging. 2013 Dec 12. doi: 10.1002/jmri.24534. [Epub ahead of print]

PMID:
24339027
[PubMed - as supplied by publisher]
5.

Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla.

Park SH, Choi HY, Hahn SY.

J Magn Reson Imaging. 2013 Dec 18. doi: 10.1002/jmri.24519. [Epub ahead of print]

PMID:
24353241
[PubMed - as supplied by publisher]
6.

Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study.

MERCURY Study Group.

Radiology. 2007 Apr;243(1):132-9. Epub 2007 Feb 28.

PMID:
17329685
[PubMed - indexed for MEDLINE]
7.

Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.

Kim SH, Cha ES, Kim HS, Kang BJ, Choi JJ, Jung JH, Park YG, Suh YJ.

J Magn Reson Imaging. 2009 Sep;30(3):615-20. doi: 10.1002/jmri.21884.

PMID:
19711411
[PubMed - indexed for MEDLINE]
8.

Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.

Oto A, Yang C, Kayhan A, Tretiakova M, Antic T, Schmid-Tannwald C, Eggener S, Karczmar GS, Stadler WM.

AJR Am J Roentgenol. 2011 Dec;197(6):1382-90. doi: 10.2214/AJR.11.6861.

PMID:
22109293
[PubMed - indexed for MEDLINE]
9.

Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy.

Verma S, Rajesh A, Morales H, Lemen L, Bills G, Delworth M, Gaitonde K, Ying J, Samartunga R, Lamba M.

AJR Am J Roentgenol. 2011 Feb;196(2):374-81. doi: 10.2214/AJR.10.4441.

PMID:
21257890
[PubMed - indexed for MEDLINE]
10.

Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor.

Heo SH, Jeong YY, Shin SS, Kim JW, Lim HS, Lee JH, Koh YS, Cho CK, Kang HK.

Korean J Radiol. 2010 May-Jun;11(3):295-303. doi: 10.3348/kjr.2010.11.3.295. Epub 2010 Apr 29.

PMID:
20461183
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?

Regier M, Derlin T, Schwarz D, Laqmani A, Henes FO, Groth M, Buhk JH, Kooijman H, Adam G.

Eur J Radiol. 2012 Oct;81(10):2913-8. doi: 10.1016/j.ejrad.2011.11.050. Epub 2011 Dec 23.

PMID:
22197090
[PubMed - indexed for MEDLINE]
12.

Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness.

Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H, Komai Y, Yokoyama M, Saito K, Fujii Y, Kawakami S, Kihara K.

Eur Radiol. 2011 Oct;21(10):2178-86. doi: 10.1007/s00330-011-2174-7. Epub 2011 Jun 18.

PMID:
21688007
[PubMed - indexed for MEDLINE]
13.

Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer.

Elmi A, Hedgire SS, Covarrubias D, Abtahi SM, Hahn PF, Harisinghani M.

Clin Radiol. 2013 Oct;68(10):e524-31. doi: 10.1016/j.crad.2013.05.094. Epub 2013 Jul 2.

PMID:
23830776
[PubMed - indexed for MEDLINE]
14.

Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and 18 F-FDG-PET/CT: Correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.

Giganti F, De Cobelli F, Canevari C, Orsenigo E, Gallivanone F, Esposito A, Castiglioni I, Ambrosi A, Albarello L, Mazza E, Gianolli L, Staudacher C, Del Maschio A.

J Magn Reson Imaging. 2013 Nov 8. doi: 10.1002/jmri.24464. [Epub ahead of print]

PMID:
24214734
[PubMed - as supplied by publisher]
15.

Clinical applications of diffusion-weighted-MRI in prostate cancer.

Wibulpolprasert P, Phongkitkarun S, Chalermsanyakorn P.

J Med Assoc Thai. 2013 Aug;96(8):967-75.

PMID:
23991605
[PubMed - indexed for MEDLINE]
16.

Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.

Goyal A, Sharma R, Bhalla AS, Gamanagatti S, Seth A, Iyer VK, Das P.

Acta Radiol. 2012 Apr 1;53(3):349-58. doi: 10.1258/ar.2011.110415.

PMID:
22496427
[PubMed - indexed for MEDLINE]
17.

Repeatability of diffusion-weighted imaging in rectal cancer.

Intven M, Reerink O, Philippens ME.

J Magn Reson Imaging. 2014 Jul;40(1):146-50. doi: 10.1002/jmri.24337. Epub 2013 Oct 11.

PMID:
24127172
[PubMed - in process]
18.

Multi-parametric MRI of rectal cancer - do quantitative functional MR measurements correlate with radiologic and pathologic tumor stages?

Attenberger UI, Pilz LR, Morelli JN, Hausmann D, Doyon F, Hofheinz R, Kienle P, Post S, Michaely HJ, Schoenberg SO, Dinter DJ.

Eur J Radiol. 2014 Jul;83(7):1036-43. doi: 10.1016/j.ejrad.2014.03.012. Epub 2014 Mar 22.

PMID:
24791649
[PubMed - in process]
19.

Role of magnetic resonance diffusion-weighted imaging in differentiating lacrimal masses.

Zhang F, Sha Y, Qian J, Huang WH, Li XF, Wang SJ, Ye XP.

J Magn Reson Imaging. 2013 Oct 11. doi: 10.1002/jmri.24392. [Epub ahead of print]

PMID:
24127226
[PubMed - as supplied by publisher]
20.

FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.

Nakajo M, Nakajo M, Kajiya Y, Tani A, Kamiyama T, Yonekura R, Fukukura Y, Matsuzaki T, Nishimoto K, Nomoto M, Koriyama C.

Clin Nucl Med. 2012 May;37(5):475-80. doi: 10.1097/RLU.0b013e318248524a.

PMID:
22475897
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk